Glädjerus efter nya fredsuppgifter – pillersuccé lyfter Novo

from Börslunch · host EFN Ekonomikanalen

Novo Nordisk verkar ha hittat formen med hjälp av sina nylanserade viktminskningspiller, men konkurrenten Eli Lilly ligger dem hack i hälarna. Hur går det för de stora läkemedelsbolagen och var hittar man nästa stora vinnare? Detta diskuterar vi tillsammans med Ulrica Slåne Bjerke, investeringschef Arctic Asset Management och Johan Unnerus, analytiker på SB1 Markets. Programmet leds av Gabriel Mellqvist och Nike Mekibes.

What this episode covers

NOW PLAYING

0:00 28:23

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Börslunch?

This episode is 28 minutes long.

When was this Börslunch episode published?

This episode was published on May 6, 2026.

What is this episode about?

Can I download this Börslunch episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!